Homocystinuria

DBCOND0000908Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesHemic and Lymphatic Diseases

Homocystinuria is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
CBS Deficiency
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0010516ICD-10E72.11SNOMED CT11282001MedDRA10020365UMLSC0019880

What you can answer from here — as of October 24, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
12Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Homocystinuria share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In